All Stories

  1. Biased GPR3 activation is a safer therapeutic target for Alzheimer's disease

    Article • Proceedings of the National Academy of Sciences, September 2022, Proceedings of the National Academy of Sciences

    Amantha Thathiah, Yunhong Huang